603168 莎普爱思
午间休市 02-09 11:29:37
资讯
新帖
简况
每周股票复盘：莎普爱思（603168）2025年预亏最高3.42亿
证券之星 · 02-01
每周股票复盘：莎普爱思（603168）2025年预亏最高3.42亿
莎普爱思（603168）披露2025年度业绩预亏公告，1月29日股价上涨0.13%
证券之星 · 01-29
莎普爱思（603168）披露2025年度业绩预亏公告，1月29日股价上涨0.13%
每周股票复盘：莎普爱思（603168）预计2025年净利为负
证券之星 · 01-18
每周股票复盘：莎普爱思（603168）预计2025年净利为负
莎普爱思最新公告：二氟尼柳片通过仿制药一致性评价
证券之星 · 01-15
莎普爱思最新公告：二氟尼柳片通过仿制药一致性评价
莎普爱思（603168）披露2025年度业绩预亏的提示性公告，1月12日股价上涨0.65%
证券之星 · 01-12
莎普爱思（603168）披露2025年度业绩预亏的提示性公告，1月12日股价上涨0.65%
莎普爱思(603168.SH)：预计2025年度归属于母公司所有者的净利润为负值
智通财经 · 01-12
莎普爱思(603168.SH)：预计2025年度归属于母公司所有者的净利润为负值
每周股票复盘：莎普爱思（603168）股东减持14.0万股 股价涨0.52%
证券之星 · 01-11
每周股票复盘：莎普爱思（603168）股东减持14.0万股 股价涨0.52%
莎普爱思（603168）披露股东集中竞价减持股份结果公告，1月9日股价上涨0.65%
证券之星 · 01-09
莎普爱思（603168）披露股东集中竞价减持股份结果公告，1月9日股价上涨0.65%
每周股票复盘：陈德康减持莎普爱思（603168）361.1万股
证券之星 · 2025-12-28
每周股票复盘：陈德康减持莎普爱思（603168）361.1万股
莎普爱思（603168）披露股东减持股份结果公告，12月25日股价上涨0.39%
证券之星 · 2025-12-25
莎普爱思（603168）披露股东减持股份结果公告，12月25日股价上涨0.39%
12月4日莎普爱思发布公告，股东减持321.1万股
证券之星 · 2025-12-04
12月4日莎普爱思发布公告，股东减持321.1万股
每周股票复盘：莎普爱思（603168）修订公司章程获高票通过
证券之星 · 2025-11-23
每周股票复盘：莎普爱思（603168）修订公司章程获高票通过
莎普爱思（603168）披露修订《公司章程》议案获股东会通过，11月19日股价下跌2.16%
证券之星 · 2025-11-19
莎普爱思（603168）披露修订《公司章程》议案获股东会通过，11月19日股价下跌2.16%
每周股票复盘：莎普爱思（603168）获新药临床试验批准
证券之星 · 2025-11-16
每周股票复盘：莎普爱思（603168）获新药临床试验批准
莎普爱思(603168.SH)获得去氧肾上腺素酮咯酸溶液临床试验批准通知书
智通财经 · 2025-11-14
莎普爱思(603168.SH)获得去氧肾上腺素酮咯酸溶液临床试验批准通知书
莎普爱思（603168）披露拟回购注销部分限制性股票公告，11月13日股价上涨1.69%
证券之星 · 2025-11-13
莎普爱思（603168）披露拟回购注销部分限制性股票公告，11月13日股价上涨1.69%
莎普爱思（603168）披露举办2025年三季度业绩说明会的公告，11月11日股价上涨0.48%
证券之星 · 2025-11-11
莎普爱思（603168）披露举办2025年三季度业绩说明会的公告，11月11日股价上涨0.48%
每周股票复盘：莎普爱思（603168）4992万股限售股将上市
证券之星 · 2025-11-09
每周股票复盘：莎普爱思（603168）4992万股限售股将上市
莎普爱思（603168）披露向特定对象发行股票限售股上市流通公告，11月03日股价上涨0.62%
证券之星 · 2025-11-03
莎普爱思（603168）披露向特定对象发行股票限售股上市流通公告，11月03日股价上涨0.62%
每周股票复盘：莎普爱思（603168）Q3净利增195.54%
证券之星 · 2025-11-02
每周股票复盘：莎普爱思（603168）Q3净利增195.54%
加载更多
公司概况
公司名称：
浙江莎普爱思药业股份有限公司
所属行业：
医药制造业
上市日期：
2014-07-02
主营业务：
浙江莎普爱思药业股份有限公司的主营业务是药品研发、生产、销售及医疗服务。公司的主要产品是滴眼液、大输液、头孢克肟、诊疗服务。公司于2024年被授予科技进步先进单位及创新赋能奖荣誉。
发行价格：
21.85
{"stockData":{"symbol":"603168","market":"SH","secType":"STK","nameCN":"莎普爱思","latestPrice":7.51,"timestamp":1770607777000,"preClose":7.45,"halted":0,"volume":2717526,"delay":0,"changeRate":0.0081,"floatShares":373000000,"shares":374000000,"eps":-0.1739,"marketStatus":"午间休市","change":0.06,"latestTime":"02-09 11:29:37","open":7.5,"high":7.59,"low":7.47,"amount":20497600,"amplitude":0.0161,"askPrice":7.52,"askSize":6,"bidPrice":7.51,"bidSize":323,"shortable":0,"etf":0,"ttmEps":-0.1739,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770613200000},"marketStatusCode":3,"adr":0,"adjPreClose":7.45,"symbolType":"stock","openAndCloseTimeList":[[1770600600000,1770607800000],[1770613200000,1770620400000]],"highLimit":8.2,"lowLimit":6.71,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":374126505,"isCdr":false,"pbRate":1.72,"roa":"--","roe":"1.72%","epsLYR":-0.33,"committee":0.162148,"marketValue":2810000000,"turnoverRate":0.0073,"status":0,"floatMarketCap":2798000000},"requestUrl":"/m/hq/s/603168","defaultTab":"news","newsList":[{"id":"2608772460","title":"每周股票复盘：莎普爱思（603168）2025年预亏最高3.42亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2608772460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608772460?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:18","pubTimestamp":1769887092,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，莎普爱思报收于7.35元，较上周的7.79元下跌5.65%。本周，莎普爱思1月26日盘中最高价报7.83元。本周关注点业绩披露要点：莎普爱思预计2025年扣非净利润亏损2.28亿元至3.42亿元。公司公告汇总：莎普爱思因商誉减值预计2025年度归母净利润亏损2.128亿元至3.192亿元。公司公告汇总浙江莎普爱思药业股份有限公司预计2025年度实现归属于母公司所有者的净利润为-31,920.00万元到-21,280.00万元，扣除非经常性损益后的净利润为-34,200.00万元到-22,800.00万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2607397340","title":"莎普爱思（603168）披露2025年度业绩预亏公告，1月29日股价上涨0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607397340","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607397340?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:25","pubTimestamp":1769700315,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，莎普爱思报收于7.53元，较前一交易日上涨0.13%，最新总市值为28.17亿元。该股当日开盘7.5元，最高7.6元，最低7.4元，成交额达5772.27万元，换手率为2.06%。近日，浙江莎普爱思药业股份有限公司发布2025年度业绩预亏公告。公告显示，公司预计2025年度实现归属于母公司所有者的净利润为-31,920.00万元到-21,280.00万元，扣除非经常性损益后的净利润为-34,200.00万元到-22,800.00万元。本期业绩预告未经注册会计师审计，数据为初步核算结果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2604258759","title":"每周股票复盘：莎普爱思（603168）预计2025年净利为负","url":"https://stock-news.laohu8.com/highlight/detail?id=2604258759","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604258759?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:34","pubTimestamp":1768678449,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，莎普爱思报收于7.53元，较上周的7.69元下跌2.08%。本周，莎普爱思1月13日盘中最高价报7.84元。业绩披露要点莎普爱思发布业绩预告，预计2025年全年归属净利润为负值。公司公告汇总莎普爱思2025年度业绩预亏的提示性公告浙江莎普爱思药业股份有限公司预计2025年度归属于母公司所有者的净利润为负值，主要由于需计提商誉减值准备所致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2603674699","title":"莎普爱思最新公告：二氟尼柳片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2603674699","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603674699?lang=zh_cn&edition=full","pubTime":"2026-01-15 15:43","pubTimestamp":1768463008,"startTime":"0","endTime":"0","summary":"莎普爱思(603168.SH)公告称，公司收到国家药品监督管理局核发的二氟尼柳片的《药品补充申请批准通知书》，同意批准增加0.5g规格的补充申请，视同通过仿制药质量和疗效一致性评价。该药品适用于类风湿性关节炎、骨关节炎等，累计研发投入约为714.92万元。此次获得批准进一步丰富了公司产品线，但药品生产和销售受政策、市场等多因素影响，存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500020102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2602546003","title":"莎普爱思（603168）披露2025年度业绩预亏的提示性公告，1月12日股价上涨0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602546003","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602546003?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:39","pubTimestamp":1768228779,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘，莎普爱思报收于7.74元，较前一交易日上涨0.65%，最新总市值为28.96亿元。该股当日开盘7.69元，最高7.74元，最低7.61元，成交额达4755.5万元，换手率为1.66%。公司近日发布公告称，浙江莎普爱思药业股份有限公司预计2025年度归属于母公司所有者的净利润为负值，主要由于需计提商誉减值准备所致。公司将按规定尽快披露2025年度业绩预告，并在审计过程中如发现影响业绩预告的重大变化将及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200037619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2602185235","title":"莎普爱思(603168.SH)：预计2025年度归属于母公司所有者的净利润为负值","url":"https://stock-news.laohu8.com/highlight/detail?id=2602185235","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602185235?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:26","pubTimestamp":1768209981,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)发布公告，经公司财务部门初步测算，公司预计2025年度归属于母公司所有者的净利润为负值，主要系公司预计需计提商誉减值准备导致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391662.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"莎普爱思(603168.SH)：预计2025年度归属于母公司所有者的净利润为负值","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603168"],"gpt_icon":0},{"id":"2602361605","title":"每周股票复盘：莎普爱思（603168）股东减持14.0万股 股价涨0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602361605","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602361605?lang=zh_cn&edition=full","pubTime":"2026-01-11 04:00","pubTimestamp":1768075238,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，莎普爱思报收于7.69元，较上周的7.36元上涨4.48%。本周，莎普爱思1月9日盘中最高价报7.74元。股本股东变化股东增减持1月9日莎普爱思发布公告，股东上海景兴实业投资有限公司于2025年10月10日至2026年1月9日合计减持14.0万股，占公司目前总股本的0.0374%。变动期间该股股价上涨0.52%，截至1月9日收盘报7.69元。公司公告汇总莎普爱思关于股东集中竞价减持股份结果公告截至2025年9月27日，上海景兴持有莎普爱思3.4535%股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2602583372","title":"莎普爱思（603168）披露股东集中竞价减持股份结果公告，1月9日股价上涨0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602583372","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602583372?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:44","pubTimestamp":1767969850,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，莎普爱思报收于7.69元，较前一交易日上涨0.65%，最新总市值为28.77亿元。该股当日开盘7.63元，最高7.74元，最低7.57元，成交额达4043.03万元，换手率为1.42%。公司近日发布公告称，截至2025年9月27日，上海景兴持有莎普爱思3.4535%股份。本次减持后，上海景兴持股比例降至3.4327%。公告显示，本次减持计划已实施完毕，实际减持情况与此前披露的减持计划一致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900041334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2594242634","title":"每周股票复盘：陈德康减持莎普爱思（603168）361.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2594242634","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594242634?lang=zh_cn&edition=full","pubTime":"2025-12-28 03:46","pubTimestamp":1766864771,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，莎普爱思报收于7.53元，较上周的7.74元下跌2.71%。本周，莎普爱思12月22日盘中最高价报7.85元。本周关注点股本股东变化：股东陈德康减持361.1万股，占总股本0.91%。股本股东变化股东增减持12月25日莎普爱思发布公告，股东陈德康于2025年12月4日至12月24日合计减持40.0万股，占公司目前总股本的0.1069%。减持后，陈德康持有公司股份40,260,004股，占当前总股本的10.76%。公司总股本因限制性股票回购注销减少至374,126,505股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2594230578","title":"莎普爱思（603168）披露股东减持股份结果公告，12月25日股价上涨0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594230578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594230578?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:59","pubTimestamp":1766674754,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，莎普爱思报收于7.67元，较前一交易日上涨0.39%，最新总市值为28.7亿元。公司近日发布公告称，浙江莎普爱思药业股份有限公司股东陈德康在2025年9月25日至12月24日期间，通过集中竞价交易方式减持公司股份3,611,000股，占公司总股本的0.91%，减持价格区间为8.10～8.52元/股，减持总金额30,171,459元。减持后，陈德康持有公司股份40,260,004股，占当前总股本的10.76%。公司总股本因限制性股票回购注销减少至374,126,505股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2588002759","title":"12月4日莎普爱思发布公告，股东减持321.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588002759","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588002759?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:01","pubTimestamp":1764838870,"startTime":"0","endTime":"0","summary":"证券之星消息，12月4日莎普爱思发布公告《莎普爱思:莎普爱思关于持股5%以上股东权益变动触及1%刻度的提示性公告》，其股东陈德康于2025年7月9日至2025年12月3日间合计减持321.1万股，占公司目前总股本的0.8583%，变动期间该股股价上涨6.96%，截止12月3日收盘报8.3元。股东增减持详情见下表：根据莎普爱思2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400025607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2585210519","title":"每周股票复盘：莎普爱思（603168）修订公司章程获高票通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2585210519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585210519?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:52","pubTimestamp":1763841133,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，莎普爱思报收于7.62元，较上周的8.48元下跌10.14%。本周，莎普爱思11月17日盘中最高价报8.55元。莎普爱思当前最新总市值28.51亿元，在化学制药板块市值排名136/151，在两市A股市值排名4584/5167。本周关注点公司公告汇总：莎普爱思2025年第二次临时股东会审议通过修订《公司章程》议案，同意股份数占出席会议股东所持表决权的99.8454%。出席会议的股东及代理人共145人，代表有表决权股份总数的26.0488%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2584947549","title":"莎普爱思（603168）披露修订《公司章程》议案获股东会通过，11月19日股价下跌2.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584947549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584947549?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:27","pubTimestamp":1763562441,"startTime":"0","endTime":"0","summary":"截至2025年11月19日收盘，莎普爱思报收于8.16元，较前一交易日下跌2.16%，最新总市值为30.53亿元。该股当日开盘8.34元，最高8.37元，最低8.1元，成交额达4604.93万元，换手率为1.51%。公司近日发布公告称，浙江莎普爱思药业股份有限公司于2025年11月19日召开2025年第二次临时股东会，审议通过了关于修订《公司章程》的议案。出席会议的股东及代理人共145人，代表有表决权股份总数的26.0488%。议案为特别决议事项，已获得出席股东所持表决权三分之二以上通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900040085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2583541836","title":"每周股票复盘：莎普爱思（603168）获新药临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2583541836","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583541836?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:53","pubTimestamp":1763239987,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，莎普爱思报收于8.48元，较上周的8.08元上涨4.95%。本周，莎普爱思11月14日盘中最高价报8.55元。本周关注点公司公告汇总：莎普爱思获去氧肾上腺素酮咯酸溶液临床试验批准。莎普爱思关于召开2025年第二次临时股东会的提示性公告浙江莎普爱思药业股份有限公司将于2025年11月19日召开2025年第二次临时股东会，会议由董事会召集，采取现场投票与网络投票相结合方式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2583224573","title":"莎普爱思(603168.SH)获得去氧肾上腺素酮咯酸溶液临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2583224573","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583224573?lang=zh_cn&edition=full","pubTime":"2025-11-14 16:31","pubTimestamp":1763109104,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司获得国家药品监督管理局核准签发的关于去氧肾上腺素酮咯酸溶液的《药物临床试验批准通知书》(通知书编号：2025LP03018)，公司拟于条件具备后开展临床试验。该药品主要适用于白内障手术或人工晶状体置换手术过程中维持散瞳，防止手术中瞳孔缩小并且缓解术后眼部疼痛。截至公告披露日，去氧肾上腺素酮咯酸溶液项目累计研发投入约555.63万元人民币。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2583568925","title":"莎普爱思（603168）披露拟回购注销部分限制性股票公告，11月13日股价上涨1.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583568925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583568925?lang=zh_cn&edition=full","pubTime":"2025-11-13 17:33","pubTimestamp":1763026421,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，莎普爱思报收于8.42元，较前一交易日上涨1.69%，最新总市值为31.5亿元。近日，莎普爱思发布《2025年第二次临时股东会会议资料》公告，称因2023年股票期权与限制性股票激励计划中部分激励对象离职及2024年度公司层面业绩考核不达标，公司拟回购注销限制性股票1,798,500股。本次回购注销完成后，公司股份总数将由375,925,005股变更为374,126,505股，注册资本相应由375,925,005元变更为374,126,505元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300030409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2582354223","title":"莎普爱思（603168）披露举办2025年三季度业绩说明会的公告，11月11日股价上涨0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582354223","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582354223?lang=zh_cn&edition=full","pubTime":"2025-11-11 17:26","pubTimestamp":1762853198,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，莎普爱思报收于8.29元，较前一交易日上涨0.48%，最新总市值为31.02亿元。该股当日开盘8.24元，最高8.33元，最低8.16元，成交额达6994.42万元，换手率为2.27%。公司近日发布公告称，浙江莎普爱思药业股份有限公司将于2025年11月18日15:30-16:30通过网络互动方式在价值在线平台举行2025年三季度业绩说明会，介绍公司经营业绩、发展战略等情况。投资者可提前通过指定链接或小程序提问，说明会后可通过平台查看会议内容。公司已披露2025年三季度报告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100028262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2582861620","title":"每周股票复盘：莎普爱思（603168）4992万股限售股将上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2582861620","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582861620?lang=zh_cn&edition=full","pubTime":"2025-11-09 03:53","pubTimestamp":1762631591,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：莎普爱思49,921,506股限售股将于2025年11月10日上市流通公司公告汇总申万宏源证券承销保荐有限责任公司对莎普爱思非公开发行股票限售股上市流通事项出具核查意见，确认本次49,921,506股限售股上市流通符合相关法规要求，信息披露真实准确完整，无异议。莎普爱思发布关于向特定对象发行股票限售股上市流通的公告，本次上市流通的限售股数量为49,921,506股，上市流通日期为2025年11月10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2580214921","title":"莎普爱思（603168）披露向特定对象发行股票限售股上市流通公告，11月03日股价上涨0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580214921","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580214921?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:43","pubTimestamp":1762180997,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘，莎普爱思报收于8.05元，较前一交易日上涨0.62%，最新总市值为30.12亿元。公司近日发布公告称，浙江莎普爱思药业股份有限公司非公开发行股票限售股即将上市流通，上市股数为49,921,506股，上市流通日期为2025年11月10日。本次限售股为非公开发行股份，涉及发行对象上海养和实业有限公司和林弘远，分别认购47,095,761股和2,825,745股，限售期均为36个月。截至公告日，相关股东已严格履行股份锁定承诺。保荐机构对公司本次限售股上市流通无异议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300036335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2580470144","title":"每周股票复盘：莎普爱思（603168）Q3净利增195.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580470144","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580470144?lang=zh_cn&edition=full","pubTime":"2025-11-02 08:18","pubTimestamp":1762042699,"startTime":"0","endTime":"0","summary":"本周关注点来自业绩披露要点：莎普爱思2025年第三季度归母净利润576.94万元，同比上升195.54%。来自公司公告汇总：莎普爱思将于2025年11月19日召开第二次临时股东会，审议修订公司章程议案。股本股东变化截至2025年9月30日，莎普爱思股东户数为2.83万户，较6月30日增加670户，增幅2.43%。业绩披露要点莎普爱思2025年三季报显示，前三季度实现主营收入3.51亿元，同比下降2.44%；归母净利润2763.22万元，同比增长189.85%；扣非净利润431.97万元，同比增长108.6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770611906736,"stockEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":-0.0106},{"period":"3month","weight":-0.078},{"period":"6month","weight":-0.0904},{"period":"1year","weight":0.094},{"period":"ytd","weight":0.0122}],"compareEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1184},{"period":"1year","weight":0.243},{"period":"ytd","weight":0.0244}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江莎普爱思药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"28285人(较上一季度增加2.43%)","perCapita":"13170股","listingDate":"2014-07-02","address":"浙江省嘉兴市平湖市经济开发区新明路1588号","registeredCapital":"37412万元","survey":" 浙江莎普爱思药业股份有限公司的主营业务是药品研发、生产、销售及医疗服务。公司的主要产品是滴眼液、大输液、头孢克肟、诊疗服务。公司于2024年被授予科技进步先进单位及创新赋能奖荣誉。","listedPrice":21.85},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莎普爱思,603168,莎普爱思股票,莎普爱思股票老虎,莎普爱思股票老虎国际,莎普爱思行情,莎普爱思股票行情,莎普爱思股价,莎普爱思股市,莎普爱思股票价格,莎普爱思股票交易,莎普爱思股票购买,莎普爱思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}